CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical stage company developing telomere-targeting immunotherapies for cancer, today reported positive preliminary ...
(WASHINGTON) — The Biden administration has blacklisted and sanctioned dozens of Chinese government research institutes and private-sector tech firms, accusing them of weaponizing technology for use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results